Publication | Open Access
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
94
Citations
14
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1